CollPlant Biotechnologies Provides a Corporate Update [Yahoo! Finance]
CollPlant Biotechnologies Ltd. - Ordinary Shares (CLGN)
US:NASDAQ Investor Relations:
collplant.com/investor-relation
Company Research
Source: Yahoo! Finance
In This Article CLGN - Additional patent granted for photocurable dermal filler - Update on AbbVie dermal filler program and achievement of contingent payment - Plan for cost reductions in place to extend cash runway REHOVOT, Israel Feb. 12, 2025 /PRNewswire/ -- CollPlant Biotechnologies ( NASDAQ : CLGN), or 'CollPlant', a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen for tissue regeneration and medical aesthetics, today provided a corporate update. Dermal filler, a product candidate currently under development Photocurable Dermal Filler Program: Additional Patent Granted CollPlant today announced it has been granted U.S. Patent No. 12,186,449 related to its photocurable dermal filler product candidate. The patent relates to polymerizable solutions that are comprised of modified recombinant human collagen (rhCollagen) and other constituents such as hyaluronic acid. The Patent will
Show less
Read more
Impact Snapshot
Event Time:
CLGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLGN alerts
High impacting CollPlant Biotechnologies Ltd. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
CLGN
News
- CollPlant Biotechnologies (NASDAQ:CLGN) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $12.00 price target on the stock.MarketBeat
- COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE [Yahoo! Finance]Yahoo! Finance
- COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEPR Newswire
- COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTSPR Newswire
- CollPlant Expands its rhCollagen Distribution Capabilities in the United States and CanadaPR Newswire
CLGN
Earnings
- 11/26/25 - Miss
CLGN
Sec Filings
- 11/28/25 - Form SCHEDULE
- 11/26/25 - Form 6-K
- 11/26/25 - Form 6-K
- CLGN's page on the SEC website